Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30384 | 0.77 | — | — | |
| SCHEMBL10534019 | 0.76 | — | — | |
| SCHEMBL28931612 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL29217970 | 0.74 | — | — | |
| SCHEMBL3391417 | 0.73 | — | — | |
| SCHEMBL1512980 | 0.71 | FDPS (0.41) | — | |
| SCHEMBL14764569 | 0.71 | LPAR2 (0.37) | LPAR2LPAR3 | |
| SCHEMBL27779834 | 0.70 | — | — | |
| Cyclohexane SCHEMBL9114841 | 0.70 | MAPT (0.31) | — | |
| Benzene SCHEMBL1538489 | 0.70 | CYP3A4 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322878-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2023-10-12 | — | — | US | disclosed |
| US-11578110-B2 | Compounds for inducing tissue formation and uses thereof | HISTIDE AG (CH) | 2023-02-14 | — | — | US | disclosed |
| US-20220267394-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2022-08-25 | — | — | US | disclosed |
| US-20190225651-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2019-07-25 | — | — | US | disclosed |
| US-10201487-B2 | Hair cosmetic composition which comprises a plant lecithin | BASF SE (DE) | 2019-02-12 | — | — | US | disclosed |
| US-20190016770-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2019-01-17 | — | — | US | disclosed |
| US-20180305408-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2018-10-25 | — | — | US | disclosed |
| US-20180208635-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HISTIDE AG (CH) | 2018-07-26 | — | — | US | disclosed |
| EP-3341390-A2 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | Histide AG (CH) | 2018-07-04 | — | — | EP | disclosed |
| EP-3341397-A2 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | Histide AG (CH) | 2018-07-04 | — | — | EP | disclosed |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-20110217255-A1 | BLOCK COPOLYMERS AND THEIR USE | BASF SE (DE) | 2011-09-08 | — | — | US | disclosed |
| US-20110150796-A1 | PRECIPITATION POLYMERIZATION IN THE PRESENCE OF GLYCERIN MONOSTEARATE | BASF SE (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110015280-A1 | AMPHOLYTIC COPOLYMER, PRODUCTION THEREOF, AND USE OF THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2011-01-20 | — | — | US | disclosed |
| US-7727445-B2 | Method for manufacturing optical film | KONICA MINOLTA OPTO, INC. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20100048655-A1 | Comb Polymers and Use Thereof for the Production of Active or Effective Ingredient Formulations | BASF SE (DE) | 2010-02-25 | — | — | US | disclosed |
| US-20090230576-A1 | Method for Manufacturing Optical Film | KONICA MINOLTA OPTO, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090041813-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
| US-20080227871-A1 | Ampholytic Copolymer, Production Thereof, and Use of the Same | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080187669-A1 | Method For Waterproofing Lignocellulosic Materials | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048655-A1 | Comb Polymers and Use Thereof for the Production of Active or Effective Ingredient Formulations | MCCC2, C9, C1S | LPAR2 2201/4885LPAR3 1710/4885 |
| US-20110217255-A1 | BLOCK COPOLYMERS AND THEIR USE | FGB, CYBA, PPIB | LPAR2 3064/4885LPAR3 2857/4885 |
| US-20110150796-A1 | PRECIPITATION POLYMERIZATION IN THE PRESENCE OF GLYCERIN MONOSTEARATE | HACL2, DAGLB, HAO2 | LPAR2 332/4885LPAR3 923/4885 |
| US-20080227871-A1 | Ampholytic Copolymer, Production Thereof, and Use of the Same | IDUA, ABHD16A, IDE | LPAR2 1392/4885LPAR3 771/4885 |
| US-11578110-B2 | Compounds for inducing tissue formation and uses thereof | HDGF, HGF, BMP4 | LPAR2 357/4885LPAR3 367/4885 |
| US-20190225651-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | SPG11, PTGIS, VIPR1 | LPAR2 597/4885LPAR3 643/4885 |
| US-10201487-B2 | Hair cosmetic composition which comprises a plant lecithin | LRAT, PHOSPHO1, LPCAT1 | LPAR2 106/4885LPAR3 58/4885 |
| US-20230322878-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HDGF, HGF, BMP4 | LPAR2 357/4885LPAR3 367/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | LPAR2 3381/4885LPAR3 1973/4885 |
| US-20180305408-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | SPHK1, CMKLR1, SPHK2 | LPAR2 133/4885LPAR3 286/4885 |
| US-20220267394-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HDGF, HGF, FGF2 | LPAR2 234/4885LPAR3 236/4885 |
| US-20190016770-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HDGF, HGF, FGF2 | LPAR2 234/4885LPAR3 236/4885 |
| US-20110015280-A1 | AMPHOLYTIC COPOLYMER, PRODUCTION THEREOF, AND USE OF THE SAME | ABHD16A, ABHD6, IDUA | LPAR2 431/4885LPAR3 193/4885 |
| US-20180208635-A1 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | HDGF, HGF, BMP4 | LPAR2 395/4885LPAR3 379/4885 |
| US-20090041813-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | LPAR2 3381/4885LPAR3 1973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.